aMoon
Venture capitalRa'anana · Seed–Late Stage · 17 people tracked
Investment thesis
aMoon invests in early and late-stage healthcare companies pursuing disruptive, cutting-edge solutions addressing significant medical gaps. The firm leverages its global network of scientists, physicians, entrepreneurs, and investors to support portfolio companies through dedicated platform services including talent acquisition, ecosystem partnerships, and proprietary market intelligence. aMoon aims to make healthcare more affordable, improve quality, and increase access to care through technology-driven innovation.
Source: firm website, verified Jul 21, 2026.
Team · 17 people
from the firm's websiteMBA-qualified general partner at aMoon.
MBA-qualified general partner contributing to aMoon's investment strategy.
Medical doctor and MBA holder who co-founded aMoon and serves as managing partner.
PhD and MBA holder serving as general partner and leading aMoon Alpha initiatives.
PhD holder and partner at aMoon.
Advisor and Master of Public Administration degree holder serving as partner.
PhD holder serving as managing partner at aMoon.
Principal at aMoon.
MBA holder serving as principal at aMoon.
Medical doctor and MBA holder serving as associate at aMoon.
Medical doctor serving as analyst at aMoon.
PhD holder serving as associate at aMoon.
Chief People Officer and Chief of Staff at aMoon with over two decades of human capital leadership experience in high-growth, global technology companies. Previously served as Chief People and Corporate Development Officer at Cellebrite, where she managed strategic planning, talent acquisition, organizational development, and M&A integration. She holds an MSc in Management Engineering and is a certified life and business coach.
MBA-qualified portfolio manager at aMoon.
Medical doctor and MBA holder serving as associate at aMoon.
Intern at aMoon.
PhD holder serving as analyst at aMoon.
What they invest in
from 3 of 45 portfolio companiesMedical Devices ×2Biotech ×1Deep Tech ×1Enterprise Software ×1Healthtech ×1Retail Tech ×1SaaS ×1
HQs:United States×2
Investments · 45 tracked
founders shown can be your intro pathBiopharmaceutical company developing novel antibody drug conjugates to treat high unmet need diseases including cancer.
Iantrek develops medical devices and technologies for micro-interventional ophthalmic surgery, specifically targeting glaucoma treatment through uveoscleral pathway outflow enhancement for surgeons and ophthalmologists.
Medical DevicesElkins Park, US
Seer provides a platform for sales associates in luxury retail to create and share customized lookbooks and style recommendations with clients. The tool replaces manual processes like image curation and email recommendations with an integrated application designed for in-store and online sales teams.
Enterprise SoftwareRetail TechSaaSSan Francisco, US
Christina Czap(Co-Founder, CEO)inFelipe Saint-Jean(Co-Founder, CTO)in
Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.
BiotechDeep TechHealthtechMedical Devices
Frequently asked questions
- What stage does aMoon invest at?
- aMoon invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does aMoon focus on?
- aMoon focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is aMoon located?
- aMoon is headquartered in Ra'anana, IL.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.